BRPI0607932A2 - polimorfo cci-779, processo para preparar polimorfo cci-779, composição farmacêutica, kit, e método para preparar uma composição farmacêutica - Google Patents

polimorfo cci-779, processo para preparar polimorfo cci-779, composição farmacêutica, kit, e método para preparar uma composição farmacêutica

Info

Publication number: BRPI0607932A2
Authority: BR; Brazil
Prior art keywords: polymorph; cci; preparing; pharmaceutical composition; kit
Prior art date: 2005-02-09

Application number

BRPI0607932A

Other languages

English (en)

Inventor

Subodh S Deshmukh

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-09

Filing date

2006-01-25

Publication date

2016-11-08

2006-01-25 Application filed by Wyeth Corp filed Critical Wyeth Corp

2016-11-08 Publication of BRPI0607932A2 publication Critical patent/BRPI0607932A2/pt

Links

CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 title 2
239000008194 pharmaceutical composition Substances 0.000 title 2
229960000235 temsirolimus Drugs 0.000 title 2
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0607932A 2005-02-09 2006-01-25 polimorfo cci-779, processo para preparar polimorfo cci-779, composição farmacêutica, kit, e método para preparar uma composição farmacêutica BRPI0607932A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US65137405P	2005-02-09	2005-02-09
PCT/US2006/003098 WO2006086172A1 (en)	2005-02-09	2006-01-25	Cci-779 polymorph and use thereof

Publications (1)

Publication Number	Publication Date
BRPI0607932A2 true BRPI0607932A2 (pt)	2016-11-08

Family

ID=36570939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0607932A BRPI0607932A2 (pt)	2005-02-09	2006-01-25	polimorfo cci-779, processo para preparar polimorfo cci-779, composição farmacêutica, kit, e método para preparar uma composição farmacêutica

Country Status (19)

Country	Link
US (1)	US7442707B2 (pt)
EP (1)	EP1856130A1 (pt)
JP (1)	JP2008530090A (pt)
KR (1)	KR20070107030A (pt)
CN (1)	CN101115759A (pt)
AR (1)	AR052479A1 (pt)
AU (1)	AU2006213061A1 (pt)
BR (1)	BRPI0607932A2 (pt)
CA (1)	CA2595766A1 (pt)
CR (1)	CR9257A (pt)
GT (1)	GT200600044A (pt)
IL (1)	IL184560A0 (pt)
MX (1)	MX2007009590A (pt)
NO (1)	NO20073725L (pt)
PE (1)	PE20060996A1 (pt)
RU (1)	RU2007129264A (pt)
TW (1)	TW200638932A (pt)
WO (1)	WO2006086172A1 (pt)
ZA (1)	ZA200706628B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8551512B2 (en) *	2004-03-22	2013-10-08	Advanced Cardiovascular Systems, Inc.	Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
WO2007067565A1 (en) *	2005-12-07	2007-06-14	Wyeth	Process for the preparation of purified crystalline cci-779
TW200804399A (en) *	2005-12-07	2008-01-16	Wyeth Corp	Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
TW200736603A (en) *	2005-12-07	2007-10-01	Wyeth Corp	Methods for preparing crystalline rapamycin and measuring crystallinity of rapamycin compounds using differential scanning calorimetry
TW200824713A (en) *	2006-10-18	2008-06-16	Wyeth Corp	Processes for the synthesis of individual isomers of mono-PEG CCI-779
JP5643770B2 (ja) *	2009-01-21	2014-12-17	バイオコン・リミテッドＢｉｏｃｏｎＬｉｍｉｔｅｄ	シロリムスの安定性の決定方法およびその安定形態の調製方法
US10682415B2 (en)	2013-07-22	2020-06-16	Wisconsin Alumni Research Foundation	Thermogel formulation for combination drug delivery
CN109020995A (zh) *	2017-06-12	2018-12-18	鲁南制药集团股份有限公司	一种替西罗莫司的晶型物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5362718A (en)	1994-04-18	1994-11-08	American Home Products Corporation	Rapamycin hydroxyesters
US6277983B1 (en) *	2000-09-27	2001-08-21	American Home Products Corporation	Regioselective synthesis of rapamycin derivatives
TWI256395B (en)	1999-09-29	2006-06-11	Wyeth Corp	Regioselective synthesis of rapamycin derivatives
MXPA04001523A (es)	2001-08-22	2004-05-31	Wyeth Corp	Dialdehidos de rapamicina.
DE60206512T2 (de)	2001-08-22	2006-06-22	Wyeth	Rapamycin 29-enole
CA2528173A1 (en)	2003-07-16	2005-02-03	Wyeth	Cci-779 isomer c
RU2339639C2 (ru) *	2003-08-07	2008-11-27	Уайт	Региоселективный синтез cci-779
WO2005023254A1 (en)	2003-09-03	2005-03-17	Wyeth	Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
CA2562952A1 (en)	2004-04-14	2005-11-10	Wyeth	Regiospecific synthesis of rapamycin 42-ester derivatives

2006
- 2006-01-25 AU AU2006213061A patent/AU2006213061A1/en not_active Abandoned
- 2006-01-25 BR BRPI0607932A patent/BRPI0607932A2/pt not_active IP Right Cessation
- 2006-01-25 JP JP2007555124A patent/JP2008530090A/ja not_active Withdrawn
- 2006-01-25 RU RU2007129264/04A patent/RU2007129264A/ru not_active Application Discontinuation
- 2006-01-25 MX MX2007009590A patent/MX2007009590A/es not_active Application Discontinuation
- 2006-01-25 KR KR1020077018347A patent/KR20070107030A/ko not_active Withdrawn
- 2006-01-25 EP EP06734012A patent/EP1856130A1/en not_active Withdrawn
- 2006-01-25 WO PCT/US2006/003098 patent/WO2006086172A1/en not_active Ceased
- 2006-01-25 CN CNA200680004408XA patent/CN101115759A/zh not_active Withdrawn
- 2006-01-25 CA CA002595766A patent/CA2595766A1/en not_active Abandoned
- 2006-01-25 US US11/339,728 patent/US7442707B2/en not_active Expired - Fee Related
- 2006-02-03 PE PE2006000136A patent/PE20060996A1/es not_active Application Discontinuation
- 2006-02-06 TW TW095103902A patent/TW200638932A/zh unknown
- 2006-02-07 GT GT200600044A patent/GT200600044A/es unknown
- 2006-02-08 AR ARP060100451A patent/AR052479A1/es unknown
2007
- 2007-07-12 IL IL184560A patent/IL184560A0/en unknown
- 2007-07-18 NO NO20073725A patent/NO20073725L/no not_active Application Discontinuation
- 2007-07-18 CR CR9257A patent/CR9257A/es not_active Application Discontinuation
- 2007-08-08 ZA ZA200706628A patent/ZA200706628B/xx unknown

Also Published As

Publication number	Publication date
GT200600044A (es)	2006-11-09
US20060178392A1 (en)	2006-08-10
CN101115759A (zh)	2008-01-30
RU2007129264A (ru)	2009-03-20
EP1856130A1 (en)	2007-11-21
ZA200706628B (en)	2010-01-27
MX2007009590A (es)	2007-09-12
AR052479A1 (es)	2007-03-21
US7442707B2 (en)	2008-10-28
NO20073725L (no)	2007-09-05
CA2595766A1 (en)	2006-08-17
KR20070107030A (ko)	2007-11-06
WO2006086172A1 (en)	2006-08-17
TW200638932A (en)	2006-11-16
IL184560A0 (en)	2007-10-31
JP2008530090A (ja)	2008-08-07
PE20060996A1 (es)	2006-11-13
CR9257A (es)	2007-11-23
AU2006213061A1 (en)	2006-08-17

Similar Documents

Publication	Publication Date	Title
BR122020011920A2 (pt)	2020-08-25	composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto
BRPI0814611A2 (pt)	2015-01-27	Composição, processo para preparar uma composição, e, uso de uma composição
BRPI0611956A2 (pt)	2018-07-31	composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
BRPI0911685A2 (pt)	2015-10-13	composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0812847A2 (pt)	2014-12-09	Uretano acrilado, composição, e, método para reticular pelo menos parcialmente a composição
BRPI0812851A2 (pt)	2014-09-30	Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BRPI0720703A2 (pt)	2014-02-18	Método para a preparação de uma peneira molecular, e, peneira molecular de poros pequenos
BRPI0816513A2 (pt)	2015-03-24	Composição farmacêutica e método para preparar a suspensão sólida
FI20050913L (fi)	2007-03-14	Menetelmä peroksihappojen valmistamiseksi
BRPI0717044A2 (pt)	2013-10-01	ferramenta de formaÇÕa, e, mÉtodo para testar uma formaÇço
BRPI0714959A2 (pt)	2015-04-22	Composição de peneira molecular, método para fabricação e processo para uso do mesmo
BRPI0909691A2 (pt)	2015-08-04	Composto, método para preparar um composto, e, composição farmacêutica
BRPI0817727A2 (pt)	2017-05-16	composição de graxa lubrificante, e, método para preparar uma composição de graxa
BRPI0812647A2 (pt)	2014-09-30	"composição e método para produzir a composição"
BRPI0607423A2 (pt)	2016-11-08	forma microcristalina de um composto, processo para a preparação da mesma, uso de uma forma microcristalina, composição farmacêutica e processo para a preparação da mesma, e, produto
BRPI0811275A2 (pt)	2014-12-23	Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BRPI0816904A2 (pt)	2015-03-17	Formas sólida, amorfa e cristalina, composição farmacêutica, e, método para tratar uma doença
FI20050257L (fi)	2006-09-10	Uudet merkinnät ja menetelmä niiden valmistamiseksi
BRPI0720705B8 (pt)	2017-07-04	método para preparar uma composição de espumação, e, composição de espumação
BRPI0610785A2 (pt)	2016-09-13	polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição
BRPI0814471A2 (pt)	2015-02-03	Preparação de anticorpo, método para produzir a preparação de anticorpo, composição farmacêutica, kit de partes, e, uso de uma preparação de anticorpo
BRPI0612254A2 (pt)	2016-09-06	composto, formulação farmacêutica, combinação, e, processo para preparar um composto
BRPI0817721A2 (pt)	2015-03-31	Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto
BRPI0613574A2 (pt)	2016-11-16	forma cristalina isolada de um composto, método para preparar um composto, e, composição farmacêutica

Legal Events

Date	Code	Title	Description
2010-06-01	B06G	Technical and formal requirements: other requirements [chapter 6.7 patent gazette]	Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO PARECER DA PROCURADORIA MEMO/INPI/PROC/NO 074/93, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO A MESMA CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO.
2011-09-27	B11Z	Dismissal: petition dismissal - article 216, par 2 of industrial property law	Free format text: REFERENTE A PETICAO 20070108637 DE 06/08/2007.
2017-02-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2017-05-30	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]